An Official Website of the United States Government
Company Information:
Name:
NACELLE THERAPEUTICS, INC.
Address:
NACELLE THERAPEUTICS, INC.
1500 HAYES DR
MANHATTAN, KS 66502
1500 HAYES DR
MANHATTAN, KS 66502
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(785) 532-3906
Award Totals:
Award List:
CHANNEL REPLACEMENT THERAPY FOR CYSTIC FIBROSIS
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John M. Tomich
Award Amount:
$195,000.00
Abstract:
Nacelle's overall objective is to develop and commercialize a superior cystic fibrosis (CF) therapeutic, derived from a family of unique peptides that will form functional ion channels in defective cell membranes. Nacelle Therapeutics refers to this treatment modality as "Peptide-based channel… More
SYNTHETIC PEPTIDE MODULATORS OF PARACELLULAR CONDUCTANCE
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John M. Tomich
Award Amount:
$100,000.00
Abstract:
DESCRIPTION (provided by applicant): The innovative use of a synthetic peptide to modulate epithelial or endothelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interventions. Cell monolayers are a major obstacle to delivering drugs to selected… More
Enhanced Drug Access to Eye Tissues
Award Year / Program / Phase:
2004 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John M. Tomich
Award Amount:
$232,945.00
Abstract:
DESCRIPTION (provided by applicant) The innovative use of a synthetic peptide to modulate epithelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interventions. Cell monolayers are a major obstacle to delivering drugs to selected locations throughout the… More